MKI67 and breast cancer: Our mean Ki-67 proliferative index across the spectrum of neuroendocrine tumors is somewhat higher than in most reported studies, possibly due to our differences in methodology in our using automatic cell counting – while this method has been previously validated against manual counting in breast cancers, it may have a lower threshold for counting weakly positive cells than some observers.